GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pharma Foods International Co 2929.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

566

+1.80%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥63.22bn

FY2017FY2026

Net income

¥1.99bn

FY2017FY2026

Free cash flow

−¥5.19bn

FY2017FY2026

Shareholders' equity

¥13.17bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥63.22bn¥65.26bn¥62.15bn¥68.57bn¥60.19bn¥46.75bn¥15.35bn¥10.53bn¥7.94bn¥4.72bn
Gross profit¥50.66bn¥52.53bn¥48.65bn¥55.21bn¥48.06bn¥39.68bn¥12.14bn¥8.50bn¥6.31bn¥3.70bn
Research and development¥1.86bn¥1.40bn¥978.0m¥840.0m¥766.0m¥522.0m¥437.7m¥317.2m¥274.2m¥242.0m
Operating income¥2.63bn¥2.37bn¥5.11bn¥3.61bn¥1.10bn¥5.68bn¥805.6m¥583.2m¥226.6m¥89.4m
Net income¥1.99bn¥368.0m¥3.21bn¥3.08bn−¥374.0m¥3.84bn¥690.9m¥499.9m¥313.7m¥101.3m
Diluted earnings per share68.6212.75114.18106.78-12.90132.3623.7917.2110.803.49

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥35.12bn¥32.78bn¥36.57bn¥36.23bn¥31.16bn¥20.94bn¥10.10bn¥8.73bn¥6.33bn¥5.84bn
Cash and short-term investments¥7.79bn¥9.16bn¥15.67bn¥16.31bn¥8.85bn¥9.79bn¥3.28bn¥4.32bn¥2.93bn¥2.86bn
Total liabilities¥21.95bn¥21.23bn¥24.99bn¥26.60bn¥24.09bn¥12.48bn¥5.19bn¥4.42bn¥2.42bn¥2.25bn
Debt¥17.17bn¥12.66bn¥16.90bn¥20.12bn¥16.88bn¥4.91bn¥3.60bn¥3.12bn¥1.43bn¥1.59bn
Shareholders' equity¥13.17bn¥11.55bn¥11.59bn¥9.63bn¥7.07bn¥8.46bn¥4.91bn¥4.32bn¥3.89bn¥3.59bn
Shares outstanding29m29m28m29m29m29m29m29m29m29m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−¥1.18bn−¥1.09bn¥5.49bn¥6.13bn−¥6.07bn¥5.94bn−¥547.1m¥90.7m¥415.5m¥233.9m
Capital spending−¥4.01bn−¥891.0m−¥942.0m−¥386.0m−¥467.0m−¥154.0m−¥900.0m−¥260.7m−¥42.3m−¥23.1m
Free cash flow−¥5.19bn−¥1.98bn¥4.54bn¥5.74bn−¥6.53bn¥5.78bn−¥1.45bn−¥170.0m¥373.2m¥210.8m
Dividends paid−¥723.0m−¥784.0m−¥626.0m−¥578.0m−¥871.0m−¥290.0m−¥101.6m−¥101.0m−¥101.0m−¥101.0m

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Revenue¥14.67bn¥16.11bn¥16.73bn¥15.71bn¥18.44bn¥16.96bn¥15.26bn¥14.60bn
Gross profit¥11.49bn¥12.89bn¥13.66bn¥12.62bn¥14.85bn¥13.43bn¥12.37bn¥11.88bn
Operating income¥4.06bn¥931.0m¥150.0m−¥2.51bn¥2.59bn−¥841.0m−¥259.0m¥883.0m
Net income¥3.05bn¥763.0m¥67.0m−¥1.89bn¥1.49bn−¥1.35bn−¥131.0m¥360.0m
Diluted earnings per share105.2426.342.31-65.5051.65-46.83-4.5412.83
Cash from operations¥2.38bn−¥775.0m−¥666.0m−¥2.12bn−¥110.0m−¥1.00bn−¥16.0m¥35.0m
Capital spending−¥3.41bn−¥134.0m−¥175.0m−¥295.0m−¥267.0m−¥199.0m−¥129.0m−¥296.0m
Free cash flow−¥1.03bn−¥909.0m−¥841.0m−¥2.41bn−¥377.0m−¥1.20bn−¥145.0m−¥261.0m
Total assets¥35.12bn¥34.86bn¥32.26bn¥32.62bn¥32.78bn¥32.59bn¥32.98bn¥32.97bn
Cash and short-term investments¥7.79bn¥8.77bn¥7.69bn¥8.67bn¥9.16bn¥10.35bn¥11.11bn¥11.76bn
Debt¥13.96bn¥16.96bn¥14.85bn¥14.40bn¥11.97bn¥12.46bn¥12.44bn¥12.58bn
Shareholders' equity¥13.17bn¥10.08bn¥9.77bn¥9.38bn¥11.55bn¥10.24bn¥12.05bn¥11.48bn

Financial ratios

Data as of 27 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Gross margin80.1%80.5%78.3%80.5%79.8%84.9%
Operating margin4.2%3.6%8.2%5.3%1.8%12.2%
Net margin3.1%0.6%5.2%4.5%-0.6%8.2%
Return on equity15.1%3.2%27.7%32.0%-5.3%45.4%
Return on assets5.7%1.1%8.8%8.5%-1.2%18.3%
Free cash flow yield13.6%-1.0%31.9%31.4%-26.9%29.2%
Revenue growth-3.1%5.0%-9.4%13.9%28.7%204.5%
Earnings growth440.2%-88.5%4.1%-923.5%-109.7%455.9%
Current ratio1.26x1.19x1.18x1.13x1.03x1.63x
Debt to equity1.06x1.04x1.46x2.09x2.38x0.58x
Equity ratio37.5%35.2%31.7%26.6%22.7%40.4%
Interest coverage16.35x26.03x82.48x75.21x42.46x473.58x
R&D as a share of sales2.9%2.1%1.6%1.2%1.3%1.1%
Buybacks as a share of market value-0.4%-2.8%2.7%0.5%0.1%0.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-2.7%6.2%33.7%
Operating income-10.0%-14.3%—
Net income-13.6%-12.3%54.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin80.3%79.9%80.5%80.3%
Operating margin3.9%5.3%5.6%5.4%
Net margin1.8%3.3%3.3%3.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings8.653.38.89.4-102.516.085.428.147.8111.2
Price to sales0.30.30.50.40.61.33.81.31.92.4

Dividends and splits

Per share, in the currency the company pays

Paid for 6 years. Last went ex-dividend on 29 Jan 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year12.5040.0022.0020.0025.0010.003.50
  • 2-for-1 split · 28 Jan 2015
  • 200-for-1 split · 29 Jul 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.